Atlas Trials

Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia)

Clinical trial NCT00338780 · COMPLETED

Trial details

NCT number
NCT00338780
Sponsor
Chinese University of Hong Kong
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Hepatitis B
Start date
2000-11-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.